Search results for "From ACP InternistWeekly"
Metformin appears safe for heart failure patients, analysis finds
Metformin appears to be a safe option for glycemic control in heart failure patients, according to a recent meta-analysis.
https://diabetes.acponline.org/archives/2013/05/10/7.htm
10 May 2013
Mortality, hospitalization may be similar with sitagliptin versus other oral antidiabetics
Sitagliptin was associated with similar rates of hospital admission and mortality as other glucose-lowering drugs, according to a recent study of patients with type 2 diabetes.
https://diabetes.acponline.org/archives/2013/05/10/5.htm
10 May 2013
Consensus statement offers strategies for preventing hypoglycemia
Consequences of hypoglycemia and strategies to prevent this condition in patients with diabetes were discussed in a recent consensus statement from the American Diabetes Association (ADA) and The Endocrine Society.
https://diabetes.acponline.org/archives/2013/05/10/6.htm
10 May 2013
Angina not associated with mortality in diabetes patients with coronary artery disease
Patients with type 2 diabetes and stable coronary artery disease (CAD) had similar risk of cardiovascular events and death, regardless of whether they had angina or angina-like symptoms, a study found.
https://diabetes.acponline.org/archives/2013/03/08/5.htm
8 Mar 2013
ADA recommendations increase blood pressure target to below 140 mm Hg systolic in diabetic patients
A higher maximum systolic blood pressure target for diabetics is one of the most significant changes in the American Diabetes Association's 2013 Standards of Medical Care.
https://diabetes.acponline.org/archives/2013/02/08/5.htm
8 Feb 2013
ADA recommendations increase blood pressure target to below 140 mm Hg systolic in diabetic patients
A higher maximum systolic blood pressure target for diabetics is one of the most significant changes in the American Diabetes Association's 2013 Standards of Medical Care.
https://diabetes.acponline.org/archives/2013/01/11/5.htm
11 Jan 2013
Diabetes risk from statins may be offset by reduction in cardiovascular events
Atorvastatin, 80 mg/d, carries a higher risk of developing diabetes than do lower doses, but only among patients who already have multiple risk factors, a study found.
https://diabetes.acponline.org/archives/2013/01/11/6.htm
11 Jan 2013
Sulfonylureas associated with higher CV risk than metformin
As initial monotherapy for type 2 diabetes, sulfonylureas were associated with more cardiovascular events and deaths than metformin, a new study found.
https://diabetes.acponline.org/archives/2012/11/09/5.htm
9 Nov 2012
EHRs may improve diabetes management and achievement of treatment goals, particularly among those with worst disease control
Use of a commercially available electronic health record (EHR) was associated with improved care processes and better achievement of intermediate treatment outcomes for outpatients with diabetes, a study found.
https://diabetes.acponline.org/archives/2012/10/12/5.htm
12 Oct 2012
Clopidogrel associated with decreased benefit in diabetics post-MI
Diabetics benefit less from receiving clopidogrel after myocardial infarction than non-diabetics, a study found.
https://diabetes.acponline.org/archives/2012/09/14/7.htm
14 Sep 2012